A judge has declined car dealer software supplier Pentana’s bid to withdraw admissions made over four years ago in a dispute with competitor Titan DMS.
Samsung Bioepis has successfully opposed Janssen’s bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.
Owners of apartments in Sydney’s One Central Park, who are embroiled in disputes with developer Frasers over defective planter boxes on the building’s façade, can’t get a court declaration to impact rectification works.
A judge has vacated an upcoming trial in a $27 million lawsuit against a unit of Coronation Property over alleged defects in a Liverpool high-rise.
A luxury Hamilton Island resort has lost its bid to vary the form of security ordered last year in its $15 million suit over allegedly defective rectification works completed in the wake of Cyclone Debbie.
Developer CIP Group must fork over another $1.17 million in further security for costs in a derivative case against entities associated with a 600-lot development in Brisbane.
In the first-ever civil penalty proceedings for breaches of the Privacy Act, pathology services provider Australian Clinical Labs has been ordered to pay $5.8 million over a 2022 data breach that compromised the sensitive personal information of 223,000 customers of its Medlab business.
Litigation funder Woodsford has struck back at a discrimination suit by a former female director, admitting its CEO described her male colleague as a “thrusting young buck” but denying the phrase was gendered.
Abbey Animal Health has appealed its loss in a suit seeking to invalidate rival Virbac’s patent for an antiparasitic drug.
A former authorised representative of Resilium Insurance Broking has failed to persuade an appeals court that the intermediary network breached a contract by providing its client data to a new representative.